Making Lung Cancer Clinical Trials More Inclusive: Recommendations for Expanding Eligibility Criteria.

Bonomi, Philip; Blumenthal, Gideon; Ferris, Andrea Stern; Stewart, David J; Selig, Wendy K D; Krug, Lee M; Allen, Jeff; Ison, Gwynn; Langer, Corey J; Melemed, Allen; Odogwu, Lauretta; Basu Roy, Upal; Sandler, Alan

Bonomi, Philip; Blumenthal, Gideon; Ferris, Andrea Stern; Stewart, David J; Selig, Wendy K D; Krug, Lee M; Allen, Jeff; Ison, Gwynn; Langer, Corey J; Melemed, Allen; Odogwu, Lauretta; Basu Roy, Upal; Sandler, Alan.

Afiliação

Bonomi P; Rush Medical Center, Chicago, Illinois. Electronic address: philip_bonomi@rush.edu.
Blumenthal G; U.S. Food and Drug Administration, Silver Spring, Maryland.
Ferris AS; LUNGevity Foundation, Bethesda, Maryland.
Stewart DJ; University of Ottawa, Ottawa, Ontario, Canada.
Selig WKD; WSCollaborative, McLean, Virginia.
Krug LM; Bristol-Myers Squibb, Princeton, New Jersey.
Allen J; Friends of Cancer Research, Washington, DC.
Ison G; U.S. Food and Drug Administration, Silver Spring, Maryland.
Langer CJ; University of Pennsylvania, Philadelphia, Pennsylvania.
Melemed A; Eli Lilly, Indianapolis, Indiana.
Odogwu L; U.S. Food and Drug Administration, Silver Spring, Maryland.
Basu Roy U; LUNGevity Foundation, Bethesda, Maryland.
Sandler A; Genentech, San Francisco, California.

J Thorac Oncol ; 13(6): 748-751, 2018 06.

Article em En | MEDLINE | ID: mdl-29793646

Assuntos

Ensaios Clínicos como Assunto; Definição da Elegibilidade/métodos; Neoplasias Pulmonares/epidemiologia; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ensaios Clínicos como Assunto / Definição da Elegibilidade / Neoplasias Pulmonares Tipo de estudo: Guideline Limite: Humans Idioma: En Revista: J Thorac Oncol Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google